Trump’s Plan Puts Pharma First
On the margins, Trump’s proposals might yield small improvements on drug prices, including some savings in Medicare and lower co-payment, but the proof is in the follow through. Overall, President Trump’s plan is yet another giveaway to the pharmaceutical industry and falls far short of what is needed to end the crisis of high drug prices.
Here are some links to comprehensive analyses of President Trump’s, American Patients First proposal:
MSF Responds to President Trump’s Speech on Drug Pricing
Tags
Archives
- All
- October 2020
- September 2020
- August 2020
- July 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- April 2019
- February 2019
- December 2018
- September 2018
- June 2018
- May 2018
- April 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- November 2015